Annual EPS
-$5.20
-$1.05-25.30%
31 December 2023
Summary:
Keros Therapeutics annual earnings per share is currently -$5.20, with the most recent change of -$1.05 (-25.30%) on 31 December 2023. During the last 3 years, it has fallen by -$2.27 (-77.47%). KROS annual EPS is now -3359.75% below its all-time high of -$0.15, reached on 31 December 2018.KROS EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EPS
-$1.41
-$0.16-12.80%
30 September 2024
Summary:
Keros Therapeutics quarterly earnings per share is currently -$1.41, with the most recent change of -$0.16 (-12.80%) on 30 September 2024. Over the past year, it has dropped by -$0.08 (-6.02%). KROS quarterly EPS is now -701.14% below its all-time high of -$0.18, reached on 31 December 2019.KROS Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EPS
-$5.21
-$0.08-1.56%
30 September 2024
Summary:
Keros Therapeutics TTM earnings per share is currently -$5.21, with the most recent change of -$0.08 (-1.56%) on 30 September 2024. Over the past year, it has dropped by -$0.26 (-5.25%). KROS TTM EPS is now -1173.84% below its all-time high of -$0.41, reached on 31 March 2019.KROS TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KROS EPS Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -25.3% | -6.0% | -5.3% |
| 3 y3 years | -77.5% | -62.1% | -92.3% |
| 5 y5 years | -3359.8% | -213.2% | -323.2% |
KROS EPS High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -106.3% | at low | -370.0% | at low | -106.8% | at low |
| 5 y | 5 years | -3359.8% | at low | -701.1% | at low | -323.2% | at low |
| alltime | all time | -3359.8% | at low | -701.1% | at low | -1173.8% | at low |
Keros Therapeutics EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.41(+12.8%) | -$5.21(+1.6%) |
| June 2024 | - | -$1.25(+3.3%) | -$5.13(-0.4%) |
| Mar 2024 | - | -$1.21(-9.7%) | -$5.15(-1.0%) |
| Dec 2023 | -$5.20(+25.3%) | -$1.34(+0.8%) | -$5.20(+5.1%) |
| Sept 2023 | - | -$1.33(+4.7%) | -$4.95(+9.0%) |
| June 2023 | - | -$1.27(+0.8%) | -$4.54(+3.2%) |
| Mar 2023 | - | -$1.26(+15.6%) | -$4.40(+6.0%) |
| Dec 2022 | -$4.15(+64.7%) | -$1.09(+18.5%) | -$4.15(+23.5%) |
| Sept 2022 | - | -$0.92(-18.6%) | -$3.36(+1.5%) |
| June 2022 | - | -$1.13(+11.9%) | -$3.31(+16.1%) |
| Mar 2022 | - | -$1.01(+236.7%) | -$2.85(+13.1%) |
| Dec 2021 | -$2.52 | -$0.30(-65.5%) | -$2.52(-7.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$0.87(+29.9%) | -$2.71(+11.1%) |
| June 2021 | - | -$0.67(-1.5%) | -$2.44(+2.1%) |
| Mar 2021 | - | -$0.68(+38.8%) | -$2.39(-0.8%) |
| Dec 2020 | -$2.93(+277.0%) | -$0.49(-18.3%) | -$2.41(+15.0%) |
| Sept 2020 | - | -$0.60(-3.2%) | -$2.09(+7.7%) |
| June 2020 | - | -$0.62(-11.2%) | -$1.94(+14.6%) |
| Mar 2020 | - | -$0.70(+296.6%) | -$1.70(+20.5%) |
| Dec 2019 | -$0.78(+417.1%) | -$0.18(-60.9%) | -$1.41(+14.3%) |
| Sept 2019 | - | -$0.45(+21.1%) | -$1.23(+57.7%) |
| June 2019 | - | -$0.37(-9.1%) | -$0.78(+90.9%) |
| Mar 2019 | - | -$0.41 | -$0.41 |
| Dec 2018 | -$0.15 | - | - |
FAQ
- What is Keros Therapeutics annual earnings per share?
- What is the all time high annual EPS for Keros Therapeutics?
- What is Keros Therapeutics annual EPS year-on-year change?
- What is Keros Therapeutics quarterly earnings per share?
- What is the all time high quarterly EPS for Keros Therapeutics?
- What is Keros Therapeutics quarterly EPS year-on-year change?
- What is Keros Therapeutics TTM earnings per share?
- What is the all time high TTM EPS for Keros Therapeutics?
- What is Keros Therapeutics TTM EPS year-on-year change?
What is Keros Therapeutics annual earnings per share?
The current annual EPS of KROS is -$5.20
What is the all time high annual EPS for Keros Therapeutics?
Keros Therapeutics all-time high annual earnings per share is -$0.15
What is Keros Therapeutics annual EPS year-on-year change?
Over the past year, KROS annual earnings per share has changed by -$1.05 (-25.30%)
What is Keros Therapeutics quarterly earnings per share?
The current quarterly EPS of KROS is -$1.41
What is the all time high quarterly EPS for Keros Therapeutics?
Keros Therapeutics all-time high quarterly earnings per share is -$0.18
What is Keros Therapeutics quarterly EPS year-on-year change?
Over the past year, KROS quarterly earnings per share has changed by -$0.08 (-6.02%)
What is Keros Therapeutics TTM earnings per share?
The current TTM EPS of KROS is -$5.21
What is the all time high TTM EPS for Keros Therapeutics?
Keros Therapeutics all-time high TTM earnings per share is -$0.41
What is Keros Therapeutics TTM EPS year-on-year change?
Over the past year, KROS TTM earnings per share has changed by -$0.26 (-5.25%)